<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01992666</url>
  </required_header>
  <id_info>
    <org_study_id>2012.769</org_study_id>
    <secondary_id>2012-A01449-34</secondary_id>
    <nct_id>NCT01992666</nct_id>
  </id_info>
  <brief_title>GENetic &amp; Immunologic Abnomalies in Systemic Lupus Erythematosus</brief_title>
  <acronym>GENIAL</acronym>
  <official_title>GENetic &amp; Immunologic Abnomalies in Systemic Lupus Erythematosus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease for which the aetiology&#xD;
      includes genet-ic and environmental factors. It is rare in children as compared to adults.&#xD;
      The severity may be related to greater involvement of genetic factors in children. The impact&#xD;
      of genetics in the development of SLE is important, and the risk of recurrence in siblings&#xD;
      evaluated by lambda S ratio is 30 in SLE, while it is 15 for type-1 diabetes and 8 rheumatoid&#xD;
      arthritis, thereby indicating high impact of genetics in SLE.&#xD;
&#xD;
      Recently, the group of Professor Yanick Crow in Manchester and other teams has identified new&#xD;
      forms of lupus Mendelian genetics. The TREX1 and genes involved in the SAMHD1 frostbite&#xD;
      lupus.&#xD;
&#xD;
      Nearly 2 % of all adult subjects with SLE have a heterozygous mutation in the TREX1 gene,&#xD;
      which therefore represents the first genetic cause of SLE. The team of Professor Crow also&#xD;
      identified the ACP5 gene that is responsible for SLE associated with Spondylo-epiphyseal&#xD;
      enchondro-epiphyseal dysplasia (syndromic lupus). Other groups have identified mutations in&#xD;
      two genes encoding a DNAse (DNAse1 and DNAse1L3) responsible for familial monogenic forms of&#xD;
      SLE. These new genes SLE were identified through research of germ-line mutations in cases of&#xD;
      lupus syndromic or family. In collaboration with Professor Crow, we are currently undergoing&#xD;
      characterization of a novel gene of SLE in a family and we have identified a second locus&#xD;
      identified in another family. The identification of these genes provides a better&#xD;
      understanding of the mechanisms regulating immune tolerance in humans. The frequency of these&#xD;
      genetic forms is not known. There is very little data on the immunological phenotype of these&#xD;
      patients.&#xD;
&#xD;
      This is a clinical study to investigate the genetic and immunological abnormalities&#xD;
      associated with pediatric SLE. The aim are to:&#xD;
&#xD;
        -  study the genetics of pediatric SLE (or syndromic or family) and to search for mutations&#xD;
           in the known genetic lupus or new genes in collaboration with Professor Yanick Crow.&#xD;
&#xD;
        -  study the lymphocyte subpopulations and serum cytokines in pediatric patients with SLE&#xD;
           (or syndromic or family) in the large Rhône- Alpes- Auvergne area.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">October 2016</completion_date>
  <primary_completion_date type="Actual">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>New genes identification</measure>
    <time_frame>Once. At inclusion.</time_frame>
    <description>Description: Identification of genetic mutations in the following genes: TREX1, SAMHD1, ACP5, DNAse1, DNAse1L3, or in new lupus genes.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immunological genotype and clinical abnormalities correlation</measure>
    <time_frame>Once. At inclusion</time_frame>
    <description>Correlate genotype to immunological (interferon alpha, …) and clinical abnormalities (microcrania, growth retardation, …)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Immunological component</measure>
    <time_frame>Once. At inclusion</time_frame>
    <description>Identification of specific immunological factors of pediatric patients with SLE (or syndromic or family)</description>
  </other_outcome>
  <other_outcome>
    <measure>Characterization of sub-groups: size, articular manifestations (SLEDAI), hematology (hemoglobin, platelets, G White, ANA, ds-DNA, C3, C4, CH50, creatinine, proteinuria.</measure>
    <time_frame>Once. At inclusion</time_frame>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">271</enrollment>
  <condition>Systemic Lupus Erythematosus (SLE)</condition>
  <arm_group>
    <arm_group_label>Blood sampling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <description>Immunologic and genetic analysis from a single blood sample.</description>
    <arm_group_label>Blood sampling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Male or female subject, major or minor of any age with SLE (defined according to the&#xD;
             ACR criteria)&#xD;
&#xD;
               -  Onset pediatric (&lt;18 years) OR&#xD;
&#xD;
               -  Syndromic Lupus (associated with growth retardation, neurological deficit not&#xD;
                  related to lupus, frostbite, lymphoproliferation, the kidney malformations,&#xD;
                  heart, lung, brain calcifications) OR&#xD;
&#xD;
               -  Lupus in context with familial consanguinity OR&#xD;
&#xD;
               -  Familial cases (2 cases of SLE related first degree relative) OR related topic of&#xD;
                  the first degree to a lupus patient participant (if family lupus or related&#xD;
                  parents) OR&#xD;
&#xD;
               -  mother/father's lupus patient (in cas of simplex lupus)&#xD;
&#xD;
          2. A person or beneficiary entitled to a social security scheme or similar&#xD;
&#xD;
          3. Informed consent signed by the person (or parent / holding parental authority for&#xD;
             minors)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        - none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexandre Belot, Dr</last_name>
    <role>Study Director</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service d'hématologie / oncologie pédiatrique - CHU</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Néphrologie Pédiatrique - CHU Besançon</name>
      <address>
        <city>Besançon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Femme Mère Enfant</name>
      <address>
        <city>Bron</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Néphrologie Pédiatrique</name>
      <address>
        <city>Clermont Ferrand</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de pédiatrie - CHU Fort de France</name>
      <address>
        <city>Fort De France</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Néphrologie et Rhumatologie Pédiatrique</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Rhumatologie Pédiatrique - Hôpital de Bicêtre</name>
      <address>
        <city>Le Kremlin Bicêtre</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de médecine interne - Centre de référence des maladies rares</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de néphrologie, endocrinologie, maladie métabolique et hématologie bénigne pédiatriques - Hôpital Jeanne de Flandre</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>édiatrie générale, urgences et maladies infectieuses, Hôpital Salengro</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Néphrologie - Hôpital Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre de néphrologie et de transplantation rénale - Hôpital de la conception</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de médecine infantile- Hôpital Nord</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de médecine interne - Hôpitaux privés de Metz</name>
      <address>
        <city>Metz</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ervice d'urgence et post-urgences pédiatriques - CHU Arnaud de Villeneuve</name>
      <address>
        <city>Montpellier</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service médecine infantile 2</name>
      <address>
        <city>Nancy</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de néphrologie pédiatrique - CHU de Nantes</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service d'immunologie et rhumatologie pédiatrique - Centre de référence de maladies rhumatologiques et inflammatoires rares en pédiatrie-Hôpital Necker-Enfants malades</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de médecine interne - Hôpital Saint Antoine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de pédiatrie générale - Hôpital Robert-Debré</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Médecine Interne Adulte - Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69495</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Rhumatologie - Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service pédiatrie grands enfants-adolescents - CHU Hôpital Sud</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Nord</name>
      <address>
        <city>Saint Etienne</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de Pédiatrie Générale - CHU Réunion</name>
      <address>
        <city>Saint Pierre</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Service de néphrologie - médecine interne - Hypertension pédiatrique - Hôpital des enfants</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>November 8, 2013</study_first_submitted>
  <study_first_submitted_qc>November 18, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2013</study_first_posted>
  <last_update_submitted>July 25, 2018</last_update_submitted>
  <last_update_submitted_qc>July 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Systemic lupus erythematosus</keyword>
  <keyword>genetic</keyword>
  <keyword>immunological</keyword>
  <keyword>pediatric</keyword>
  <keyword>mutation</keyword>
  <keyword>lupus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

